Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check7 days agoChange DetectedExpanded the Locations section to add new sites in the US (Alabama, Arizona, California, Colorado, DC, Florida, Georgia, Indiana, Maryland, Massachusetts, Missouri, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Wisconsin), Canada (Alberta, Ontario, Quebec) and a site in Barcelona, Spain; several previously listed locations were removed. The revision tag updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPublications text updated to indicate PubMed publications are automatically filled; page revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check36 days agoChange DetectedDeletion of a government funding/operating status notice from the page; the study details remain unchanged.SummaryDifference0.3%

- Check58 days agoChange DetectedNew study locations were added (Hackensack Uni Medical Center; Esplugues, Barcelona, Spain, 08950) and an existing site name was updated from Hackensack University Medical Center / Esplugues de Llobregat, Barcelona, Spain to Esplugues, Barcelona, Spain, 08950.SummaryDifference0.5%

- Check79 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check86 days agoChange DetectedMajor update to medical topic taxonomy: replaces broader leukemia/hematology terms with specific lymphoma and virus-related infections, and updates the revision version to v3.1.0.SummaryDifference2%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.